HHS: 'Novel Antimicrobial Drug Development and Access: U.S. Government Support and Opportunities'
December 13, 2024
December 13, 2024
WASHINGTON, Dec. 13 (TNSres) -- The U.S. Department of Health and Human Services issued the following issue brief (No. xxx) on November 18, 2024, by Casey Sullivan, Cody R. Fisher and Julia Taenzer entitled "Novel Antimicrobial Drug Development and Access: U.S. Government Support and Opportunities."
Here are excerpts:
* * *
The pipeline and commercial market for novel antimicrobial drugs is insufficient to address current and future patient needs . . .
Here are excerpts:
* * *
The pipeline and commercial market for novel antimicrobial drugs is insufficient to address current and future patient needs . . .